-
公开(公告)号:US20240117030A1
公开(公告)日:2024-04-11
申请号:US18175796
申请日:2023-02-28
Applicant: Pfizer Inc.
Inventor: Rita Diane AGOSTINELLI , James Reasoner APGAR , Eric Matthew BENNETT , Laird BLOOM , Ting CHEN , Aaron Michael D'ANTONA , Arnab DE , Fang JIN , Marion Teresa KASAIAN , Matthew Allister LAMBERT , Kimberly Ann MARQUETTE , Virginie MCMANUS , Jessica Haewon MIN DEBARTOLO , Nicole Melissa PICHE-NICHOLAS , Richard Thomas SHELDON , Lioudmila TCHISTIAKOVA , Alexander Michael Shuford BARRON , Richard Lee GIESECK, III , Xiaotian ZHONG
CPC classification number: C07K16/247 , A61K45/06 , A61P35/00 , A61K2039/505
Abstract: The present invention relates to antibodies that specifically bind to one or more of IL-4, IL-13, IL-33, TSLP, and p40. The present invention further relates to antibodies that bind to one of IL-4, IL-13, IL-33, or TSLP. The invention further relates to multispecific antibodies that specifically bind to IL-4 and IL-13, and at least one other target. The present invention relates to multispecific antibodies that bind IL-4, IL-13, and one of IL-33, TSLP, or p40. The present invention also pertains to related molecules, e.g. nucleic acids which encode such antibodies or multispecific antibodies, compositions, and related methods, e.g., methods for producing and purifying such antibodies and multispecific antibodies, and their use in diagnostics and therapeutics.
-
公开(公告)号:US20200308272A1
公开(公告)日:2020-10-01
申请号:US16729421
申请日:2019-12-29
Applicant: Pfizer Inc.
Inventor: Laird BLOOM , Karl Henry NOCKA , James Reasoner APGAR , Matthew Allister LAMBERT , Mark A. FARMER
IPC: C07K16/24 , A61K39/395
Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to IL-33, as well as uses, and associated methods thereof.
-
公开(公告)号:US20180037644A1
公开(公告)日:2018-02-08
申请号:US15495172
申请日:2017-04-24
Applicant: Pfizer Inc.
Inventor: Laird BLOOM , Karl Henry NOCKA , James Reasoner APGAR , Matthew Allister LAMBERT , Mark A. FARMER
IPC: C07K16/24 , A61K39/395
Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to IL-33, as well as uses, and associated methods thereof.
-
-